A Randomized Trial of Targeted Educational Materials for Smoking Cessation in African Americans Using Transdermal Nicotine

This study examines the efficacy of targeted versus standard care smoking cessation materials among urban African American smokers. Five hundred smokers (250 to each group) are randomized to receive a culturally targeted or standard care videotape and print guide. Both groups receive 8 weeks of nicotine patches and reminder telephone calls at Weeks 1 and 3. Process outcomes include material use and salience at 1 and 4 weeks postbaseline. Smoking outcomes include 7-day abstinence, smoking reduction, and readiness to quit at 4 weeks and 6 months postbaseline. Despite greater use of the targeted guide (68.8% vs. 59.6%, p < .05), intervention participants do not perceive the targeted materials as more salient, and no significant differences are found between groups on the smoking outcomes. Findings point to the importance of greater audience segmentation and individual tailoring to better match intervention materials to the needs of the priority population.

Download Full-text

A Pilot Randomized Controlled Trial of Smoking Cessation in an Outpatient Respirology Clinic

Canadian Respiratory Journal ◽

10.1155/2015/871204 ◽

2015 ◽

Vol 22 (2) ◽

pp. 91-96 ◽

Cited By ~ 5

Author(s):

Smita Pakhale ◽

Justine Baron ◽

Michael A Armstrong ◽

Avanti Garde ◽

Robert D Reid ◽

...

Keyword(s):

Smoking Cessation ◽

Standard Care ◽

Smoking Status ◽

Controlled Trial ◽

Retention Rates ◽

Face To Face ◽

Quit Rate ◽

Intervention Adherence ◽

To Receive

OBJECTIVE: To assess the feasibility and potential effectiveness of a modified version of the Ottawa Model for Smoking Cessation in an outpatient respirology clinic.METHODS: Adult tobacco smokers attending the respirology clinic and willing to choose a quit date within one month of enrollment were randomly assigned to receive standard care or the intervention. Standard care participants received smoking cessation advice, a brochure and a prescription for smoking cessation medication if requested. Intervention participants received a $110 voucher to purchase smoking cessation pharmacotherapy and were registered to an automated calling system. Answers to automated calls determined which participants required nurse telephone counselling. Feasibility indicators included recruitment and retention rates, and intervention adherence. The effectiveness indicator was self-reported smoking status at 26 to 52 weeks.RESULTS: Forty-nine (54.4%) of 90 eligible smokers were randomly assigned to the intervention (n=23) or control (n=26) group. Self-reported smoking status at 26 to 52 weeks was available for 32 (65.3%) participants. The quit rate for intervention participants was 18.2% compared with 7.7% for controls (OR2.36 [95% CI 0.39 to 14.15]).CONCLUSION: It would be feasible to evaluate this intervention in a larger trial. Alternatives to face-to-face follow-up at the clinic are recommended.

Download Full-text

Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia

European Archives of Psychiatry and Clinical Neuroscience ◽

10.1007/s00406-014-0515-7 ◽

2014 ◽

Vol 265 (3) ◽

pp. 249-257 ◽

Cited By ~ 5

Author(s):

Kuan-Ju Chou ◽

Hsing-Kang Chen ◽

Chih-Hung Hung ◽

Tzu-Ting Chen ◽

Chun-Ming Chen ◽

...

Keyword(s):

Nicotine Patch ◽

Smoking Reduction ◽

Transdermal Nicotine ◽

Transdermal Nicotine Patch ◽

Readiness To Quit

Download Full-text

Efficacy and Safety of an Over-the-counter Transdermal Nicotine Patch as an Aid for Smoking Cessation

Archives of Family Medicine ◽

10.1001/archfami.7.6.569 ◽

1998 ◽

Vol 7 (6) ◽

pp. 569-574 ◽

Cited By ~ 31

Author(s):

M. Davidson

Keyword(s):

Smoking Cessation ◽

Nicotine Patch ◽

Efficacy And Safety ◽

Over The Counter ◽

Transdermal Nicotine ◽

Transdermal Nicotine Patch

Download Full-text

Efficacy of electronic cigarettes for tobacco smoking cessation: An adapted systematic review

European Journal of Public Health ◽

10.1093/eurpub/ckaa166.1167 ◽

2020 ◽

Vol 30 (Supplement_5) ◽

Author(s):

T O'Dowd

Keyword(s):

Smoking Cessation ◽

Cohort Studies ◽

Randomised Controlled Trials ◽

Electronic Cigarettes ◽

Controlled Trials ◽

Significant Heterogeneity ◽

Smoking Reduction ◽

Significant Difference ◽

Randomised Controlled

Abstract Background Worldwide smoking remains the leading cause of preventable morbidity and mortality. Electronic cigarettes (ECs) are increasingly used by tobacco smokers as an aid to smoking cessation; however, their efficacy remains uncertain. Methods Electronic databases, clinical trial registries and grey literature sources were searched. The aim was to examine randomised controlled trials or prospective cohort studies, published since the 2016 Cochrane review on this topic, that assessed the efficacy of ECs in achieving smoking cessation among current smokers. Results Two RCTs and five cohort studies, including a total of 16,460 participants, were eligible for inclusion. One RCT found sustained 1-year abstinence of 18.0% in the EC group versus 9.9% in the nicotine replacement therapy group (RR: 1.83; 95% CI 1.30 to 2.58; P < 0.001). The second RCT did not find a statistically significant difference in abstinence rates between EC users and non-users (RR 0.71). Of the five included cohort studies, four reported statistically significant RRs. Two found a positive association (RRs of 1.45 and 1.84) between EC use and smoking cessation but two studies showed EC use was associated with reduced smoking cessation (RRs of 0.25 and 0.35). Due to significant heterogeneity between the studies the data were deemed unsuitable for pooling into a meta-analysis. All trials assessing smoking reduction reported higher rates of reduction among EC users. No serious adverse events were reported with EC use. Follow-up periods of included trials ranged from one to four years, with an average of 1.6 years. Conclusions There is limited, low-quality evidence that ECs are an effective intervention for smoking cessation and smoking reduction. The overall quality of evidence is low as it is based on a small number of studies with inconsistent and imprecise results. Due to the short follow-up periods of the included trials, the long-term safety of ECs is unclear from this review. Key messages Limited evidence that electronic cigarettes are an effective smoking cessation intervention. Further well-designed randomised controlled trials are required to investigate the efficacy of ECs for smoking cessation.

Download Full-text

Telephone based smoking cessation intervention for adults with serious mental illness during the COVID-19 pandemic

Tobacco Use Insights ◽

10.1177/1179173x211065989 ◽

2021 ◽

Vol 14 ◽

pp. 1179173X2110659

Author(s):

Heather Leutwyler ◽

Erin Hubbard

Keyword(s):

Mental Illness ◽

Smoking Cessation ◽

San Francisco ◽

Serious Mental Illness ◽

Smoking Cessation Intervention ◽

Smoking Cessation Counseling ◽

Cessation Intervention ◽

Data Collection And Analysis ◽

Readiness To Quit ◽

The Impact

Background The high rates of smoking in adults with serious mental illness (SMI) increases risk for COVID-19 infection. The purpose of this paper is to present the results of a smoking cessation intervention that was adapted to be offered by phone during a Shelter in Place (SIP) period in San Francisco, California, at the beginning of the COVID-19 pandemic. Methods During the SIP, we offered counseling sessions by phone to five participants. At the end of each session, we assessed readiness to quit, tobacco cessation or reduction, and inquired about the impact of the shelter in place on smoking habits and mental health. Grounded theory guided data collection and analysis. Results The categories that emerged around barriers and facilitators for smoking cessation were COVID-19–related stressors, having purpose, structure and feelings of connections, and the importance of quitting aides for smoking cessation. Conclusion Offering telephone based smoking cessation counseling to adults with SMI while they shelter in place may improve their readiness to quit.

Download Full-text

Promoting smoking cessation through smoking reduction during Ramadan

Addiction ◽

10.1111/j.1360-0443.2011.03432.x ◽

2011 ◽

Vol 106 (8) ◽

pp. 1379-1380 ◽

Cited By ~ 13

Author(s):

PAUL AVEYARD ◽

RACHNA BEGH ◽

AZIZ SHEIKH ◽

AMANDA AMOS

Keyword(s):

Smoking Cessation ◽

Smoking Reduction

Download Full-text

Patterns and predictors of treatment in muscle-invasive bladder cancer (MIBC): A real-world study.

Journal of Clinical Oncology ◽

10.1200/jco.2021.39.15_suppl.e16531 ◽

2021 ◽

Vol 39 (15_suppl) ◽

pp. e16531-e16531

Author(s):

Zengqi Lu ◽

Jessica M. Clement ◽

Qi Pan ◽

Helen Swede ◽

Rajni Mehta ◽

...

Keyword(s):

Logistic Regression ◽

Real World ◽

Alternative Treatment ◽

Standard Care ◽

Strong Predictor ◽

Treatment Patterns ◽

Cancer Center ◽

Data Set ◽

Adoption Rate ◽

To Receive

e16531 Background: Among the approaches to curative-intent therapy for MIBC, neoadjuvant cisplatin-based chemotherapy (NAC) is recognized as the gold standard. The combined modality approach of concurrent chemo-radiation is also considered a standard of care. Despite guidelines recommending multidisciplinary care, studies have shown a low adoption rate of multidisciplinary approaches for MIBC. This study aimed to describe the treatment patterns for MIBC pts using real world data. Methods: Following the appropriate IRB approvals, investigators followed a common protocol under the auspices of the Rapid Case Ascertainment at the Yale Cancer Center. Manual chart review was performed on MIBC pts diagnosed in Connecticut from 2004 –2015 and treated at investigator-affiliated hospitals. Information on medical history, comorbidity, and treatment types were recorded. This data set was linked to the Surveillance, Epidemiology, and End Results (SEER) database for demographic information. The descriptive and logistic regression were used to analyze treatment patterns and predicators in each treatment lines: surgery alone, chemotherapy alone, radiation alone and standard care (NAC followed by surgery; surgery followed by adjuvant chemotherapy and concurrent chemo-radiation). Results: The number of adult MIBC pts in the cohort was 1,198. Among them, 290 (24.2%) received surgery as the only treatment; 117 (9.8%) received chemotherapy only; 100 (8.3%) received concurrent chemo-radiation; 96 (8.0%) received NAC followed by surgery. Besides age ( OR: 0.546, 95% CI: 0.289-0.986), when comparing female to male patients on the likelihood of receiving NAC to the alternative treatment types (radiation or surgery), female pts were less likely to receive NAC than males (OR: 0.421, 95% CI: 0.184-0.930). Conclusions: Regardless of demographics, the overall adoption rate of standard care was low, consisting of 236 pts (19.7%) of the population. From the logistic regression results, age was consistently shown as a predictor for receiving NAC over the alternative treatment types, and sex was identified as another strong predictor. Older and female patients were less likely to receive NAC than younger males.[Table: see text]

Download Full-text